Navigation Links
Verathon Inc., maker of GlideScope(R) Video Laryngoscopes, Introduces Free Grant Writing Kit for EMS Professionals
Date:2/1/2008

BOTHELL, Wash., Feb. 1 /PRNewswire/ -- Verathon Inc., the maker of GlideScope(R) Video Laryngoscopes, is pleased to make available a new Grant Writing Kit for EMS Professionals. The kit, which is free to EMS personnel, contains helpful information to seek out available grant monies, and tips to successfully apply for government grants and, private funding, in order to purchase EMS-related equipment and supplies.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061011/SFW044LOGO)

"We're pleased to offer this new grant writing kit to the EMS community," stated Gerald McMorrow, CEO, and Founder of Verathon. "With improved medical equipment and related funds both available, this kit is designed to offer EMS health care providers the needed "bridge" to match these two resources," McMorrow continued. "EMS personnel deserve the best tools available to do their jobs. Successful grant writing can help them get the equipment and supplies they need."

Data indicate that improved airway instruments remain an essential equipment segment for EMS facilities. Endotracheal intubation carries a higher risk of improper tube placement when performed in an out-of-hospital setting. Clinical studies report that in emergency out-of-hospital intubations, up to 25% of endotracheal tubes (ETT) are misplaced, with 66% of misplaced tubes being inserted into the esophagus.(i) Out-of-hospital intubations also carry a greater risk of complications. In a study of patients with severe head injuries undergoing endotracheal intubation, the odds of death were approximately 4 times greater for patients intubated outside the hospital.(ii) With this data in mind, Verathon designed the GlideScope(R) Ranger video laryngoscope specifically to assist in challenging pre-hospital endotracheal intubations.

The GlideScope(R) Ranger was developed to meet the needs of military physicians and paramedics
'/>"/>

SOURCE Verathon Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. European Patent Office Upholds Verathons IP Against Aircraft Medical Challenge
2. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2007 Washington State Technology Fast 50 for 4th Time in Past 6 Years
3. Verathon Inc. Introduces GlideScope(R) Ranger Single Use Video Laryngoscope for Emergency Departments, EMS and Military; Enables Fast Intubations and Eliminates Time-Consuming Disinfection
4. Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer
5. Gaiam Inc., The Leader in Innovative Lifestyle Solutions, Announces New DVD Series Created with Mayo Clinic
6. Herman Miller, Inc., Announces Strategic Acquisition of Brandrud Furniture, Inc. to Expand Its Product Offerings and Competitive Position in the Healthcare Furnishings Sector
7. New Data From Shared Health, Inc., Proves Effectiveness of Health Information Exchange for Improving Patient Outcomes at the Point of Care
8. gloStream, Inc., Announces Formation of Nationwide Certified Partner Network
9. Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics
10. Tela Sourcing, Inc., an Adaptis Company, Acquires HealthASPex Business
11. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... A US Airman, fresh from basic training ...eukemia patient whose life he saved by donating hi...an Air Base, Republic of Korea (PRWEB) November 21...irman whose blood donation saved her life, met for...ov. 21, 2008. , , , , ,Airman Tamarias Pope, 8th ...
(Date:11/21/2008)..., Fla. -- A Florida State University College of Me...overed an important new layer of regulation in the...r understanding of the way cancer begins. , Wang... the College of Medicine, said the findings will l...could lead to the design of new drugs that kill ca...
(Date:11/21/2008)... Nov. 21 The Generic,P...owing statement today from,GPhA President and CEO...ssion,(FTC) roundtable on "Emerging Health Care C...e fact that the FTC is conducting this roundtable ... that consumers have access to safe and,affordabl...
(Date:11/21/2008)...a., Nov. 21 New researc...er a smokeless, spitless tobacco product aimed at ...ave found that RJ Reynolds, Camel Snus - touted as...contains surprisingly high levels of nicotine. , ...st other snuff products," said Bruce Adkins of the...
Breaking Medicine News(10 mins):Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 2Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 3Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3
...ave shown inhaled corticosteroids can decrease a p... now say long-term use of ICS therapy is not assoc...teroids are commonly used to treat asthmatics and ...nary disorder. Researchers say these medications a...
... thought of rickets as a disease of the past. New ...blem and prevention should start before birth and ... vitamin D supplementation.// Rickets is a childho...kening of the bones, primarily caused by lack of v...
...ave shown breast cancer patients who receive radia...n and a mastectomy may be more likely to develop c...y not be the case. Researchers from the Fox Chase ...east cancer who underwent a mastectomy, breast rec...
...kidney patients have far more to be concerned abou...ciation-sponsored study shows //people with chroni... heart disease. Doctors say the most surprising fi...ople who are in the very early stages of kidney di...
Other Medicine News:
(Date:11/20/2008)...ASHINGTON, Nov. 20 The ...amp; Gender Equity: , , WHAT: World AIDS ... Tuesday, November 25, 2008 , 11:00 a.m. EST ...ngly encouraged: https://cc.readytalk.com/r/1xe41...s outpacing the number of people newly put on trea...
(Date:11/20/2008)..., , , , PHILADELPHIA, Nov. 20 /PRNe... today announced that the United States Food and D...val for PROMACTA(R) (eltrombopag) for the treatmen...une (idiopathic) thrombocytopenic purpura (ITP) wh...oids, immunoglobulins or splenectomy. The approval...
(Date:11/20/2008)... REINACH, Switzerland, November 20 /PRNewswire-F...hat the Anti-infective Drugs Advisory Committee of...voted 17 to 2 against the,approval of intravenous...for,the treatment of patients with complicated sk...ing those caused by methicillin-resistant Staphylo...
(Date:11/20/2008)...MERYVILLE, Calif., Nov. 20 /PRNewswire-FirstCall/ ...company will present results from the Phase 1B,cl...nced metastatic breast,cancer, BZL101, at the Soc...l,Conference in Atlanta, Georgia. The Company,s ...bstract and will be presented as a part of the Bes...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21 11583 1Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21 11583 2MIT develops thin film micro pharmacy 11580 1MIT develops thin film micro pharmacy 11580 2Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 11575 1Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 11575 2Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 11575 3Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 1Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 2Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 3Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 4Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 5Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 6Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 7Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 8Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 9
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: